IceCure Medical Ltd (ICCM)Healthcare | Medical Devices | Caesarea, Israel | NasdaqCM
0.37 USD
+0.01
(2.176%)
⇧
(April 21, 2026, 10:32 a.m.
EDT)
Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:10 a.m. EDT
ICCM is a high-risk, cash-burning biotech play with no dividend yield and negative earnings; despite recent $4M funding and a defined 52-week range, the technicals show significant overcorrection from $1.40 highs down to ~$0.28, resulting in sluggish momentum and poor predictive confidence for near-term price action. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.186050 |
| AutoARIMA | 0.187143 |
| AutoETS | 0.187147 |
| MSTL | 0.188125 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 20% |
| H-stat | 53.92 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 0.42 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 2.398 |
| Revenue per Share | 0.053 |
| Market Cap | 30,036,618 |
| Forward P/E | -4.63 |
| Beta | 2.52 |
| Website | https://www.icecure-medical.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.68245614 |
| Address1 | 7 Ha’Eshel St. |
| Address2 | PO Box 3163 |
| All Time High | 12.4 |
| All Time Low | 0.277 |
| Ask | 0.4745 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 406,150 |
| Average Daily Volume3 Month | 448,265 |
| Average Volume | 448,265 |
| Average Volume10Days | 406,150 |
| Beta | 2.517 |
| Bid | 0.26 |
| Bid Size | 2 |
| Book Value | 0.124 |
| City | Caesarea |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Israel |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.37 |
| Current Ratio | 2.613 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.3814 |
| Day Low | 0.3632 |
| Debt To Equity | 2.398 |
| Display Name | IceCure Medical |
| Earnings Call Timestamp End | 1,773,759,600 |
| Earnings Call Timestamp Start | 1,773,759,600 |
| Earnings Timestamp | 1,778,761,800 |
| Earnings Timestamp End | 1,778,761,800 |
| Earnings Timestamp Start | 1,778,761,800 |
| Ebitda | -14,799,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.203 |
| Enterprise To Revenue | 5.267 |
| Enterprise Value | 17,797,582 |
| Eps Current Year | -0.12 |
| Eps Forward | -0.08 |
| Eps Trailing Twelve Months | -0.24 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 972 4 623 0222 |
| Fifty Day Average | 0.51992 |
| Fifty Day Average Change | -0.14991999 |
| Fifty Day Average Change Percent | -0.28835204 |
| Fifty Two Week Change Percent | -68.24561 |
| Fifty Two Week High | 1.4 |
| Fifty Two Week High Change | -1.03 |
| Fifty Two Week High Change Percent | -0.73571426 |
| Fifty Two Week Low | 0.277 |
| Fifty Two Week Low Change | 0.092999995 |
| Fifty Two Week Low Change Percent | 0.33574003 |
| Fifty Two Week Range | 0.277 - 1.4 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,629,984,600,000 |
| Float Shares | 39,152,601 |
| Forward Eps | -0.08 |
| Forward P E | -4.625 |
| Free Cashflow | -8,915,750 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 67 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.36283 |
| Gross Profits | 1,226,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.4143 |
| Held Percent Institutions | 0.0064600003 |
| Implied Shares Outstanding | 81,180,047 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ipo Expected Date | 2,021-08-26 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MSense, a multi probe system for the treatment of multiple and larger tumors. The company serves hospitals, interventional radiological centers, ambulatory centers, and private clinics. IceCure Medical Ltd was incorporated in 2006 and is headquartered in Caesarea, Israel. |
| Long Name | IceCure Medical Ltd |
| Market | us_market |
| Market Cap | 30,036,618 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_29898934 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -15,057,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 29,395,294 |
| Number Of Analyst Opinions | 2 |
| Open | 0.37 |
| Operating Cashflow | -14,574,000 |
| Operating Margins | -3.29633 |
| Payout Ratio | 0.0 |
| Phone | 972 4 623 0333 |
| Previous Close | 0.3621 |
| Price Eps Current Year | -3.0833335 |
| Price Hint | 4 |
| Price To Book | 2.983871 |
| Price To Sales Trailing12 Months | 8.889203 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.957 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0079 |
| Regular Market Change Percent | 2.175709 |
| Regular Market Day High | 0.3814 |
| Regular Market Day Low | 0.3632 |
| Regular Market Day Range | 0.3632 - 0.3814 |
| Regular Market Open | 0.37 |
| Regular Market Previous Close | 0.3621 |
| Regular Market Price | 0.37 |
| Regular Market Time | 1,776,781,973 |
| Regular Market Volume | 84,640 |
| Return On Assets | -0.71295 |
| Return On Equity | -1.8877901 |
| Revenue Growth | 0.462 |
| Revenue Per Share | 0.053 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 81,180,045 |
| Shares Percent Shares Out | 0.0174 |
| Shares Short | 1,410,136 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 611,285 |
| Short Name | IceCure Medical Ltd. |
| Short Percent Of Float | 0.0297 |
| Short Ratio | 1.86 |
| Source Interval | 15 |
| Symbol | ICCM |
| Target High Price | 3.0 |
| Target Low Price | 2.45 |
| Target Mean Price | 2.725 |
| Target Median Price | 2.725 |
| Total Cash | 8,897,000 |
| Total Cash Per Share | 0.122 |
| Total Debt | 217,000 |
| Total Revenue | 3,379,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.24 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.75511 |
| Two Hundred Day Average Change | -0.38511002 |
| Two Hundred Day Average Change Percent | -0.5100052 |
| Type Disp | Equity |
| Volume | 84,640 |
| Website | https://www.icecure-medical.com |
| Zip | 3,079,504 |